Circadian Rhythm Disorders: Causes, Diagnosis, and Treatments

What makes a sleep problem circadian?

The circadian system helps coordinate sleepiness, alertness, melatonin secretion, body temperature, and other daily rhythms. Light reaching the eyes is its strongest environmental time cue. Work schedules, travel, limited daylight, evening light, blindness, age, and inherited differences can all affect the relationship between the internal clock and the desired sleep period.

A circadian rhythm sleep-wake disorder is more than occasionally staying up late or feeling tired after a difficult week. The sleep timing pattern must be persistent or recurrent, cause insomnia, sleepiness, or functional impairment, and fit a recognized subtype. American Academy of Sleep Medicine guidance separates intrinsic disorders, such as delayed or advanced phase, from schedule-related disorders such as shift work and jet lag [1,2].

This distinction prevents a common diagnostic error. A person with delayed sleep-wake phase disorder may sleep well from 3 AM to 11 AM but be unable to sleep from 11 PM to 7 AM. A person with chronic insomnia may sleep poorly even when allowed to choose the schedule. Obstructive sleep apnea, restless legs syndrome, medication effects, mood disorders, insufficient sleep, and substance use can mimic or compound either pattern.

The six main patterns

These labels are not interchangeable. A fixed late schedule is different from a schedule that drifts every day. Shift work disorder also requires symptoms related to the work schedule; working nights alone does not establish the diagnosis [2].

How clinicians evaluate circadian timing

A useful evaluation begins with the schedule rather than a single night of testing. Record bedtime, estimated sleep onset, awakenings, final wake time, time out of bed, naps, work or school obligations, caffeine, alcohol, medication timing, and major light exposure. Free-day sleep is especially informative because it shows what happens when an alarm is removed.

Actigraphy uses a wrist-worn device to estimate rest and activity over repeated days. The AASM suggests actigraphy as part of the assessment of circadian rhythm sleep-wake disorders, while also emphasizing that it does not replace clinical interpretation [3]. Consumer watches can reveal patterns, but a consumer sleep-stage score is not equivalent to a validated clinical device or a diagnosis.

Dim-light melatonin onset can help identify internal circadian phase in selected cases. It requires carefully timed samples under dim-light conditions, so it is not necessary or practical for every patient. Overnight polysomnography is not the routine test for a circadian disorder, but it may be appropriate when symptoms suggest sleep apnea, periodic limb movements, parasomnia, or another sleep disorder.

Seek an urgent safety plan if sleepiness has caused near-misses, crashes, errors around machinery, or unintended sleep while driving. A treatment can improve alertness without restoring normal performance.

Delayed sleep-wake phase disorder

Delayed sleep-wake phase disorder, often abbreviated DSWPD, causes difficulty falling asleep and waking at conventionally required times. When the person follows the delayed schedule, sleep duration and quality may be substantially better. The pattern is common in sleep clinics and is often confused with sleep-onset insomnia.

Treatment usually anchors a consistent wake time and then coordinates morning light, lower evening light exposure, meal and activity timing, and sometimes melatonin. The AASM guideline supports strategically timed melatonin in adults with DSWPD, but it does not establish one dose and clock time for every patient [1].

In a randomized trial of 116 adults with confirmed delayed circadian phase, 0.5 mg fast-release melatonin taken one hour before the desired bedtime, together with behavioral sleep-wake scheduling, moved actigraphic sleep onset 34 minutes earlier than placebo over four weeks and improved several patient-reported outcomes [4]. A smaller 2024 trial found that low-dose melatonin combined with evening dim light and scheduled time in bed advanced circadian phase whether timing used measured or estimated melatonin onset, but the study was preliminary [5].

Morning light is often paired with the schedule change. A randomized study in adolescents and young adults tested post-awakening bright light and morning activity, illustrating that light treatment is a timed intervention rather than simply “more light” [6]. Light given at the wrong biological time can move the clock in the unwanted direction.

Practical points include:

• keep wake time stable across workdays and free days;
• get planned light after waking if that timing is appropriate;
• reduce bright indoor and screen light late in the evening;
• avoid moving bedtime far earlier in one jump when sleepiness is not present; and
• treat coexisting insomnia, depression, ADHD, sleep apnea, or substance use on its own merits.

The circadian relevance of inherited biology is real, but a genetic test is rarely required. A well-described CRY1 variant can lengthen the circadian cycle and was associated with delayed sleep phase in affected families, yet most people with a delayed schedule do not need CRY1 testing to guide care [7].

Advanced sleep-wake phase disorder

Advanced sleep-wake phase disorder causes sleepiness in the early evening and waking earlier than desired. It is not the same as choosing to be an early riser. The schedule must cause distress or impairment, such as repeatedly falling asleep during evening activities or waking hours before the household.

The AASM conditionally suggests evening light therapy for adults with this disorder [1]. Evidence is limited, and results depend on light intensity, duration, timing, adherence, and the accuracy of the diagnosis. One controlled trial in older adults found that enhanced evening light produced subjective benefit and later sleep onset, but objective circadian and sleep outcomes were equivocal [8]. That is a reason to avoid promising a universal two-hour phase shift from a fixed lamp prescription.

Non-24-hour sleep-wake disorder

In non-24-hour sleep-wake disorder, the internal rhythm does not remain synchronized to the 24-hour day. Sleep and waking cycle through clock time over days or weeks. The condition is strongly associated with total blindness because light cannot reach the circadian system, but sighted people can also develop a non-24 pattern.

Diagnosis requires demonstrating drift across enough days. A snapshot taken during a late-sleep portion of the cycle can be mistaken for DSWPD.

Tasimelteon is a melatonin-receptor agonist indicated for non-24 in adults. Current labeling recommends 20 mg one hour before bedtime at the same time each night, without food, and notes that effects may take weeks or months [9]. In the SET trial, 20% of evaluable totally blind participants receiving tasimelteon were entrained at month one compared with 3% receiving placebo. The RESET withdrawal trial found that continued treatment was needed to maintain entrainment in most responders [10].

Those results do not mean everyone with an irregular schedule should receive tasimelteon. The trials used defined non-24 criteria and primarily enrolled totally blind adults.

Irregular sleep-wake rhythm disorder

Irregular sleep-wake rhythm disorder lacks a stable main sleep episode. Sleep is divided into several bouts across the day and night. It can occur with neurodegenerative or neurodevelopmental conditions and in environments with weak daytime activity and light cues.

The AASM guideline supports light therapy in older adults with dementia-related irregular rhythm and supports strategically timed melatonin for selected children or adolescents with neurologic disorders. It recommends against sleep-promoting medications in older adults with dementia and against melatonin for that older population because the evidence and harm balance differ by group [1].

Management should strengthen daytime and nighttime signals: regular wake and meal times, daytime light and activity, fewer long daytime naps when feasible, and a quiet dark sleep period. The plan must account for fall risk, wandering, caregiver capacity, vision, and medication burden.

Shift work disorder

Shift work disorder is diagnosed when a recurring work schedule overlaps the usual sleep period and produces persistent insomnia, excessive sleepiness, or both. It should not be used to label every night worker. Insufficient opportunity for sleep, untreated sleep apnea, sedating medication, and long commutes need separate attention.

Schedule design is the foundation. Depending on the shift pattern, a plan may use a protected daytime sleep period, a nap before or during the shift, timed workplace light, reduced morning light during the trip home, and carefully timed caffeine. Rapidly rotating schedules can make full circadian adaptation unrealistic.

Modafinil is indicated to improve wakefulness in adults with excessive sleepiness associated with shift work disorder. The current DailyMed labeling lists 200 mg approximately one hour before the work shift [11]. In a randomized trial, modafinil produced a modest improvement in objective nighttime sleep latency and reduced reported accidents or near-accidents during the commute, but treated participants still had excessive sleepiness and impaired nighttime performance [12].

Modafinil is not a substitute for adequate sleep and does not correct the underlying schedule. Current labeling includes important precautions involving serious rash, psychiatric symptoms, cardiovascular monitoring, drug interactions, and reduced effectiveness of steroidal contraceptives. Medication selection belongs with a prescriber who has evaluated the diagnosis and risks [11].

Jet lag disorder

Jet lag follows rapid travel across time zones and usually resolves as the circadian system adjusts. Eastward and westward travel require different phase shifts, so light and melatonin timing cannot be reduced to one universal schedule.

Useful steps are to protect adequate sleep before travel, begin shifting the schedule when practical, use destination light strategically, avoid driving when sleepy, and time caffeine so it does not interfere with the new sleep period. A systematic review of randomized trials found that melatonin taken near destination bedtime can reduce jet lag after travel across five or more time zones, especially eastward travel, while also noting the importance of correct timing [13].

Melatonin and light are timing tools, not generic sedatives

Melatonin can signal biological night and can also make a person sleepy. The desired effect depends on dose, formulation, and timing relative to the internal clock. Taking a large dose at an arbitrary bedtime is not equivalent to a circadian treatment plan.

Supplement quality is another limitation. Laboratory testing of 31 commercial melatonin supplements found wide variation from labeled content and detected serotonin in some products [14]. The findings came from products sold in Canada and should not be treated as a failure rate for every current U.S. product, but they show why product consistency matters when timing and dose are central.

Light therapy also has potential adverse effects, including headache, eyestrain, agitation, and unwanted phase shifts. People with eye disease, photosensitizing medication, migraine triggered by light, or bipolar-spectrum illness should discuss a plan with an appropriate clinician before starting high-intensity light exposure.

A practical appointment checklist

Bring at least one to two weeks of sleep timing records if possible. Include:

1. workday and free-day sleep periods;
2. alarm use and sleep without an alarm;
3. naps and unintended sleep;
4. work, school, commute, and caregiving demands;
5. morning and evening light exposure;
6. caffeine, alcohol, cannabis, nicotine, supplements, and medication timing;
7. snoring, witnessed breathing pauses, leg discomfort, or unusual behaviors during sleep; and
8. prior light, melatonin, schedule, or medication trials, including exact timing.

The goal is not merely an earlier bedtime. It is a stable schedule that improves daytime function without creating dangerous sleepiness or masking another disorder.

Bottom line

Circadian rhythm sleep-wake disorders are disorders of timing. The strongest diagnostic evidence is a repeated pattern showing that symptoms track clock time or a required schedule. Sleep diaries and actigraphy are more informative than a single sleep-stage score, and treatment should match the specific subtype.

Correctly timed light, darkness, behavior, and melatonin can move or stabilize the clock. Prescription wake-promoting or circadian medications have narrower roles and do not replace sleep opportunity or a complete evaluation. Claims that one lamp intensity, melatonin dose, or medication schedule works for every circadian disorder are not supported by the evidence.